Latest Insider Transactions at Recursion Pharmaceuticals, Inc. (RXRX)
This section provides a real-time view of insider transactions for Recursion Pharmaceuticals, Inc. (RXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RECURSION PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RECURSION PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,035
+0.66%
|
$560,245
$7.38 P/Share
|
|
Jan 05
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$17,500
$7.38 P/Share
|
|
Jan 05
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Jan 05
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,500
-3.4%
|
$129,500
$7.39 P/Share
|
|
Jan 04
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
91,892
+0.76%
|
$643,244
$7.8 P/Share
|
|
Jan 03
2023
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
141,646
+1.17%
|
$991,522
$7.5 P/Share
|
|
Jan 03
2023
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,573
+0.25%
|
-
|
|
Jan 03
2023
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,483
+6.51%
|
-
|
|
Jan 03
2023
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,821
+1.13%
|
-
|
|
Jan 03
2023
|
Zachary Bogue Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,407
+18.03%
|
-
|
|
Jan 03
2023
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,325
+0.02%
|
-
|
|
Dec 30
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
99,754
+0.84%
|
$698,278
$7.55 P/Share
|
|
Dec 29
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
84,622
+0.72%
|
$592,354
$7.71 P/Share
|
|
Dec 29
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
8,000
-3.78%
|
$56,000
$7.7 P/Share
|
|
Dec 29
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+3.64%
|
$8,000
$1.06 P/Share
|
|
Dec 28
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
71,299
+0.61%
|
$499,093
$7.18 P/Share
|
|
Dec 27
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
145,652
+1.25%
|
$1,019,564
$7.24 P/Share
|
|
Dec 27
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$62,195
$7.25 P/Share
|
|
Dec 23
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,378
+0.87%
|
$702,646
$7.52 P/Share
|
|
Dec 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-11.34%
|
$80,000
$8.85 P/Share
|
|
Dec 15
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.37%
|
$10,000
$2.22 P/Share
|
|
Dec 14
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.57%
|
-
|
|
Dec 13
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$71,080
$8.96 P/Share
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$22,500
$9.27 P/Share
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
37,210
-3.09%
|
$334,890
$9.03 P/Share
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+2.98%
|
-
|
|
Dec 01
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+4.94%
|
$62,500
$2.48 P/Share
|
|
Nov 29
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$71,080
$8.75 P/Share
|
|
Nov 17
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-7.28%
|
$160,000
$10.96 P/Share
|
|
Nov 17
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.79%
|
$16,000
$1.06 P/Share
|
|
Nov 16
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.56%
|
-
|
|
Nov 16
2022
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
17,770
-0.23%
|
$195,470
$11.12 P/Share
|
|
Nov 15
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,751
-1.0%
|
$63,261
$11.86 P/Share
|
|
Nov 15
2022
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,065
-0.18%
|
$11,715
$11.86 P/Share
|
|
Nov 15
2022
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,453
-0.71%
|
$15,983
$11.86 P/Share
|
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.52%
|
$120,000
$12.31 P/Share
|
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.09%
|
$10,000
$2.22 P/Share
|
|
Nov 15
2022
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
613
-0.69%
|
$6,743
$11.86 P/Share
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
2,500
-100.0%
|
$25,000
$10.1 P/Share
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,500
+50.0%
|
-
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,693
-3.09%
|
$366,930
$10.0 P/Share
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
18,500
+3.02%
|
-
|
|
Nov 03
2022
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+5.0%
|
$62,500
$2.48 P/Share
|
|
Oct 27
2022
|
Investment CO Pjsc Mubadala > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
2,551,020
+18.43%
|
$22,959,180
$9.8 P/Share
|
|
Oct 27
2022
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
16,000
-7.24%
|
$160,000
$10.72 P/Share
|
|
Oct 27
2022
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+6.75%
|
$16,000
$1.06 P/Share
|
|
Oct 19
2022
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.56%
|
-
|
|
Oct 14
2022
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.2%
|
$100,000
$10.92 P/Share
|
|
Oct 14
2022
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.82%
|
$10,000
$2.22 P/Share
|